Oncobit AG’s Post

🎉 We are excited to announce that Oncobit has successfully completed a capital increase of more than CHF 1.9 million This round was supported by both existing and new investors, including private business angels and the strategic investor ID Solutions (IDS). We are grateful for the continued trust and commitment of our shareholders and partners who share our mission to make precision cancer monitoring broadly accessible. The funding further strengthens our financial position and enables us to advance our clinical validation, regulatory, and commercialization efforts, as well as expand into additional cancer indications and new markets. A heartfelt thank you to everyone who continues to support our journey — together, we are helping shape the future of personalized cancer care. https://lnkd.in/exmbZ2cS #Oncobit #PrecisionOncology #Cancer #Monitoring #Innovation #HealthTech #SwissStartups